Find more information about Teva in your location, or contact a local representative on our local sites
North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Nuvigil and Provigil Pregnancy Registry
- Study Title
- The Nuvigil and Provigil Pregnancy Registry
- Teva Identifier
- C10953/9022
- ClinicalTrials.gov Identifier
- NCT01792583
- Study Status
- Terminated
- Trial Condition(s)
- Narcolepsy | Obstructive Sleep Apnea | Shift Work Sleep Disorder
- Interventions
- Drug: Modafinil/armodafinil
Study Description
The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during
Key Participation Requirements
- Gender
- Female
- Age Range
- Child, Adult, Older Adult
- Trial Duration
- June 30, 2009 - November 30, 2023
